Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Harm Reduction topic
No spam. Unsubscribe anytime.
House approves expanded harm-reduction framework after lengthy floor debate
Summary
After extended questioning and witness testimony about evidence, confidentiality and reporting, the House passed Senate Bill 249 (as amended), which modernizes harm-reduction programs, designates DSAM as regulator, and narrows paraphernalia penalties for personal use while preserving trafficking offenses.
The Delaware House on June 23 approved Senate Bill 2 49 with Senate Amendment 2, a comprehensive update to the state's substance-use harm-reduction framework that designates the Division of Substance Abuse and Mental Health (DSAM) as the licensing and oversight authority for harm-reduction programs.
Sponsor Representative Chukwuocha said the measure builds on more than 20 years of prior policy and expands regulated services for fixed sites, mobile units and peer-delivered services. "Approved programs will be required to make available sterile supplies, drug-checking equipment, opioid-overdose reversal medicine, and the full toolkit that public-health research shows reduces death and disease," the sponsor said. (Representative Chukwuocha)
Floor debate was lengthy and sometimes emotional. Opponents urged a more cautious, pilot-based approach and asked for clearer evidence for distributing non-needle supplies such as cookers and cotton; Representative Jones Giltner said she was not provided studies showing those items reduce overdoses and urged narrowing the bill's focus. "Stick with the science," she said. (Representative Jones Giltner)
DSAM Chief of Government Relations Joe Aronson responded that the bill includes data-collection and reporting provisions while protecting participant confidentiality to lower barriers to program participation. On funding, Aronson said current harm-reduction allocations are general-fund appropriations (about $660,400 in recent budget years) rather than opioid-settlement dollars. (Joe Aronson)
Supporters cited public-health research showing syringe programs reduce disease transmission and argued that expanding the toolkit addresses infection risks in drug-preparation steps beyond needle sharing. Representative Ross Levin recounted family loss and urged the body to "listen to science" and support programs that save lives. (Representative Ross Levin)
After debate and witness testimony, the House approved SB249 as amended. The bill includes data-collection language and directs DSAM to set reporting and program standards while allowing anonymous participation to reduce barriers to service.
The House vote reflected substantive disagreement across the chamber about scope and evidence, but the bill's supporters said the change will provide statewide consistency and regulated oversight for harm-reduction services.
